USFDA approves Lupin Bromfenac Ophthalmic Solution Ruchika Sharma24 Nov 2023 12:30 PM ISTBromfenac Ophthalmic Solution, 0.07% is indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have...
Lupin type 2 diabetes drug Canagliflozin bags USFDA tentative approval Ruchika Sharma24 Nov 2023 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration...
Lupin Dapagliflozin Tablets gets tentative USFDA okay Ruchika Sharma22 Nov 2023 1:30 PM ISTDapagliflozin Tablets are used for the treatment of type 2 diabetes.
Lupin gets USFDA nod for cholesterol lowering drug Pitavastatin Ruchika Sharma22 Nov 2023 11:37 AM ISTThe product will be manufactured at Lupin's Pithampur facility in India.
Lupin gets USFDA approval for Ganirelix Acetate Injection Ruchika Sharma18 Nov 2023 11:36 AM ISTGanirelix Acetate Injection is indicated for the inhibition of premature luteinizing hormone (LH) surges in women undergoing controlled ovarian...
Lupin collaborate with Amman Pharma for marketing, commercialization of Ranibizumab in Middle East region Ruchika Sharma11 Nov 2023 10:00 AM ISTMumbai: Global Pharma major Lupin Limited has partnered with Amman Pharmaceuticals Industries, a pharmaceutical manufacturer with operations across...
Lupin unveils Rocuronium Bromide Injection in US Ruchika Sharma8 Nov 2023 2:30 PM ISTMumbai: Global pharma major Lupin Limited today announced the launch of Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL) and 100 mg/10 mL (10...
Lupin gets tentative USFDA nod for Canagliflozin, Metformin Hydrochloride ER tablets Ruchika Sharma8 Nov 2023 10:52 AM ISTCanagliflozin and Metformin Hydrochloride Extended-Release Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in...
Indian pharmaceutical market registers 9 percent growth in September: IQVIA Report Susmita Roy3 Nov 2023 5:43 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has witnessed a spike of nine percent in September 2023, according to International Quality and...
Zydus Lifesciences, Lupin to co-market Saroglitazar Mg for chronic liver diseases treatment in India Ruchika Sharma3 Nov 2023 3:30 PM ISTUnder the terms of this agreement, Lupin will have semi-exclusive rights to co-market the product in India under the brand name LINVAS.
Lupin unveils Diazepam Rectal Gel in US Ruchika Sharma3 Nov 2023 11:34 AM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Diazepam Rectal Gel, 10 mg and 20 mg, Rectal Delivery System, after its wholly...
Lupin secures tentative USFDA nod for Selexipag for Injection Ruchika Sharma2 Nov 2023 4:30 PM ISTThis product will be manufactured at Lupin's Nagpur facility in India.
